Logistic regression; other factors associated withIGVH gene status
| Other factors . | % With unmutated V gene status (n) . | Unadjusted odds ratio (95% CI) . | Odds ratio (95% CI) after adjusting for 4 independent factors . | P after adjusting for the 4 independent factors . |
|---|---|---|---|---|
| Chromosome 17 abnormality | ||||
| N | 35% (56) | — | — | |
| Y | 60% (9) | 2.8 (1.0, 8.4) | 3.7 (0.5, 25.2) | .19 |
| Stage | ||||
| A | 33% (55) | — | — | |
| B | 86% (18) | 12.4 (3.5, 44.0) | 2.6 (0.5, 12.3) | |
| C | 60% (9) | 3.1 (1.1, 9.2) | 3.1 (0.7, 14.6) | .21 |
| Sex | ||||
| Female | 28% (24) | — | — | |
| Male | 49% (58) | 2.5 (1.4, 4.6) | 2.1 (0.9, 5.0) | .09 |
| Karyotype abnormality | ||||
| N | 22% (14) | — | — | |
| Y | 48% (67) | 3.2 (1.6, 6.3) | 1.4 (0.5, 3.7) | .58 |
| Chromosome 12 abnormality | ||||
| N | 31% (43) | — | — | |
| Y | 57% (35) | 2.9 (1.6, 5.5) | 1.3 (0.5, 3.3) | .56 |
| Karyotype evolution | ||||
| N | 34% (45) | — | — | |
| Y | 49% (18) | 1.9 (0.9, 3.9) | 1.1 (0.4, 3.0) | .90 |
| Other factors . | % With unmutated V gene status (n) . | Unadjusted odds ratio (95% CI) . | Odds ratio (95% CI) after adjusting for 4 independent factors . | P after adjusting for the 4 independent factors . |
|---|---|---|---|---|
| Chromosome 17 abnormality | ||||
| N | 35% (56) | — | — | |
| Y | 60% (9) | 2.8 (1.0, 8.4) | 3.7 (0.5, 25.2) | .19 |
| Stage | ||||
| A | 33% (55) | — | — | |
| B | 86% (18) | 12.4 (3.5, 44.0) | 2.6 (0.5, 12.3) | |
| C | 60% (9) | 3.1 (1.1, 9.2) | 3.1 (0.7, 14.6) | .21 |
| Sex | ||||
| Female | 28% (24) | — | — | |
| Male | 49% (58) | 2.5 (1.4, 4.6) | 2.1 (0.9, 5.0) | .09 |
| Karyotype abnormality | ||||
| N | 22% (14) | — | — | |
| Y | 48% (67) | 3.2 (1.6, 6.3) | 1.4 (0.5, 3.7) | .58 |
| Chromosome 12 abnormality | ||||
| N | 31% (43) | — | — | |
| Y | 57% (35) | 2.9 (1.6, 5.5) | 1.3 (0.5, 3.3) | .56 |
| Karyotype evolution | ||||
| N | 34% (45) | — | — | |
| Y | 49% (18) | 1.9 (0.9, 3.9) | 1.1 (0.4, 3.0) | .90 |